Mouse study mirrors human findings that link chemotherapy and APOE4 to cognitive issues

A chemotherapy drug commonly used to treat breast cancer alters brain structure and function in mice that express the human APOE4 gene, known to significantly increase risk of developing Alzheimer's disease, according to a new study.

from Breast Cancer News -- ScienceDaily https://ift.tt/2pBNfPt

New DNA tool predicts height, shows promise for serious illness assessment

A new DNA tool can accurately predict people's height, and more importantly, could potentially assess their risk for serious illnesses, such as heart disease and cancer.

from Women's Health News -- ScienceDaily https://ift.tt/2DYhD0h

New DNA tool predicts height, shows promise for serious illness assessment

A new DNA tool can accurately predict people's height, and more importantly, could potentially assess their risk for serious illnesses, such as heart disease and cancer.

from Women's Health News -- ScienceDaily https://ift.tt/2DYhD0h

Chemotherapy may lead to mitochondrial dysfunction in skeletal muscle

Chemotherapy drugs to treat breast cancer may promote muscle mitochondrial dysfunction, according to new research. Dysfunctional mitochondria, the energy centers of the cells, may contribute to fatigue and weakness that some people with breast cancer experience through the course of disease treatment.

from Women's Health News -- ScienceDaily https://ift.tt/2Rrqg6c

Chemotherapy may lead to mitochondrial dysfunction in skeletal muscle

Chemotherapy drugs to treat breast cancer may promote muscle mitochondrial dysfunction, according to new research. Dysfunctional mitochondria, the energy centers of the cells, may contribute to fatigue and weakness that some people with breast cancer experience through the course of disease treatment.

from Women's Health News -- ScienceDaily https://ift.tt/2Rrqg6c

Chemotherapy may lead to mitochondrial dysfunction in skeletal muscle

Chemotherapy drugs to treat breast cancer may promote muscle mitochondrial dysfunction, according to new research. Dysfunctional mitochondria, the energy centers of the cells, may contribute to fatigue and weakness that some people with breast cancer experience through the course of disease treatment.

from Breast Cancer News -- ScienceDaily https://ift.tt/2Rrqg6c

First large study details cognitive outcomes among older breast cancer patients

The first large US study of cognition in older breast cancer patients found that within the first two years after diagnosis and treatment, most women do not experience cancer-related cognitive problems.

from Women's Health News -- ScienceDaily https://ift.tt/2RoBMQ4

First large study details cognitive outcomes among older breast cancer patients

The first large US study of cognition in older breast cancer patients found that within the first two years after diagnosis and treatment, most women do not experience cancer-related cognitive problems.

from Women's Health News -- ScienceDaily https://ift.tt/2RoBMQ4

First large study details cognitive outcomes among older breast cancer patients

The first large US study of cognition in older breast cancer patients found that within the first two years after diagnosis and treatment, most women do not experience cancer-related cognitive problems.

from Breast Cancer News -- ScienceDaily https://ift.tt/2RoBMQ4

A novel molecule could spur new class of drugs for breast cancer

Researchers have designed and developed a new class of molecules that use a never-before-known mechanism that may halt or destroy breast cancer tumors, particularly for patients with drug-resistant or dangerously metastatic stages of the disease.

from Women's Health News -- ScienceDaily https://ift.tt/2NkXgd9